Vertex Pharmaceuticals (VRTX) News Today → Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad) Free VRTX Stock Alerts $446.88 -10.07 (-2.20%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 4:32 PM | marketbeat.comPortfolio Design Labs LLC Purchases New Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Portfolio Design Labs LLC acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 9,928 shares of theMay 28 at 10:40 AM | msn.comCalliditas Therapeutics’ stock surges after $1.1 billion takeover bidMay 28 at 3:18 AM | americanbankingnews.comVertex Pharmaceuticals (NASDAQ:VRTX) Lowered to Buy at StockNews.comMay 27 at 11:06 PM | investorplace.com3 Underappreciated Biotech Stocks to Buy Now: May 2024May 27 at 3:22 PM | marketbeat.comEaton Financial Holdings Company LLC Invests $3.35 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Eaton Financial Holdings Company LLC purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 8,2May 27 at 7:04 AM | marketbeat.comVertex Pharmaceuticals Q1 Earnings TranscriptMay 27 at 4:16 AM | americanbankingnews.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Director Sells $3,168,704.00 in StockMay 26 at 10:15 AM | fool.comGot $500? 3 Pharma Stocks to Buy and Hold ForeverMay 26 at 9:45 AM | fool.comIs It Too Late to Buy Vertex Pharmaceuticals Stock?May 25 at 9:31 PM | marketbeat.comNomura Asset Management Co. Ltd. Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Nomura Asset Management Co. Ltd. cut its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 150,715 shares of the pharmaceutiMay 25 at 6:23 PM | finance.yahoo.comInsider Selling: Director Bruce Sachs Sells Shares of Vertex Pharmaceuticals Inc (VRTX)May 25 at 3:25 PM | insidertrades.comBruce I. Sachs Sells 7,073 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) StockMay 25 at 10:00 AM | fool.com2 Biotech Stocks to Buy in MayMay 25 at 6:47 AM | fool.com3 High-Flying Stocks That Could Soar Even MoreMay 24, 2024 | marketbeat.com1,795 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by Skopos Labs Inc.Skopos Labs Inc. bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,795 shares of the pharmaceutical company's stoMay 24, 2024 | finance.yahoo.comNew Pain Drug Could Be Big For Vertex Stock As Shares Score BreakoutMay 24, 2024 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Director Bruce I. Sachs Sells 7,073 SharesVertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) Director Bruce I. Sachs sold 7,073 shares of the stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $448.00, for a total value of $3,168,704.00. Following the completion of the sale, the director now owns 40,000 shares in the company, valued at approximately $17,920,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.May 24, 2024 | investors.comNew Pain Drug Could Be Big For Vertex Stock As Shares Score BreakoutMay 23, 2024 | marketbeat.com2,650 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Acquired by BayBridge Capital Group LLCBayBridge Capital Group LLC purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 2,650 shares of the pharmaceutical company's stMay 23, 2024 | msn.comWalmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'May 23, 2024 | investorplace.comThe 2030 Millionaire's Club: 3 Biotech Stocks to Buy NowMay 22, 2024 | finance.yahoo.comStocks Step Back After Fed Minutes; Loar, Monday.com, VRTX In FocusMay 22, 2024 | finance.yahoo.comInsider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...May 22, 2024 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Ontario Teachers Pension Plan BoardOntario Teachers Pension Plan Board trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 27.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,920 shares of the pharmaceutical company'May 22, 2024 | businesswire.comVertex to Participate in Upcoming June Investor ConferencesMay 22, 2024 | marketbeat.comVertex Pharmaceuticals (NASDAQ:VRTX) Sets New 52-Week High at $448.59Vertex Pharmaceuticals (NASDAQ:VRTX) Reaches New 52-Week High at $448.59May 21, 2024 | marketbeat.comOxler Private Wealth LLC Buys New Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Oxler Private Wealth LLC bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 1,784 shares of the pharmaceutical company's stoMay 21, 2024 | americanbankingnews.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Given Consensus Rating of "Hold" by AnalystsMay 20, 2024 | marketbeat.comBridger Management LLC Has $19.53 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Bridger Management LLC increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 13.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 48,000 shares of the pharMay 19, 2024 | marketbeat.comNorges Bank Acquires New Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Norges Bank bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 3,042,288 shares of the pharmaceutical company's stock, valued at approximatelyMay 19, 2024 | americanbankingnews.comVertex Pharmaceuticals (NASDAQ:VRTX) Raised to Strong-Buy at StockNews.comMay 19, 2024 | marketbeat.comVertex Pharmaceuticals (NASDAQ:VRTX) Stock Rating Upgraded by StockNews.comStockNews.com upgraded Vertex Pharmaceuticals from a "buy" rating to a "strong-buy" rating in a research report on Sunday.May 18, 2024 | marketbeat.comSecurian Asset Management Inc. Trims Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Securian Asset Management Inc. lessened its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 16,324 shares of the pharmaceuticalMay 17, 2024 | marketbeat.comEFG Asset Management North America Corp. Buys 2,502 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)EFG Asset Management North America Corp. grew its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 51.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,340 shares of theMay 16, 2024 | marketbeat.comInceptionr LLC Trims Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Inceptionr LLC cut its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 69.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 819 shares of the pharmaceutical company's stocMay 15, 2024 | nz.finance.yahoo.comJennifer Schneider Elected to Vertex Board of DirectorsMay 15, 2024 | benzinga.comVertex Pharmaceuticals's Options Frenzy: What You Need to KnowMay 15, 2024 | marketbeat.comFirst Turn Management LLC Invests $33.24 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)First Turn Management LLC bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 81,683 shares of the pharmaceutical comMay 14, 2024 | marketbeat.com14,068 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by Torray Investment Partners LLCTorray Investment Partners LLC acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 14,068 shares of the pharmaceutical company's stock, valued aMay 14, 2024 | finance.yahoo.comVertex Stock Hit All-Time High, Paused, Rising AgainMay 14, 2024 | investorplace.com3 Cheap Biotech Stocks to Buy Now: May 2024May 13, 2024 | marketbeat.comPrincipal Financial Group Inc. Buys 40,005 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Principal Financial Group Inc. raised its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 12.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 368,728 shares of the pharmaceutical company's stockMay 12, 2024 | marketbeat.comMassachusetts Financial Services Co. MA Sells 265,992 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Massachusetts Financial Services Co. MA decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,625,802 shares of the pharmaceutiMay 12, 2024 | fool.comVertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart BuyMay 12, 2024 | fool.com2 Unbelievable Growth Stocks You Can Buy and Hold for the Next DecadeMay 11, 2024 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Teacher Retirement System of TexasTeacher Retirement System of Texas cut its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 60,343 shares of theMay 10, 2024 | finance.yahoo.comAlpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...May 10, 2024 | marketbeat.comWill the Biotech Sector Shift From Lagger to Leader?The biotech sector and its popular ETF, the iShares Biotechnology ETF NASDAQ: IBB, have lagged the overall market during the year, with its shares slightly red. However, in recent weeks, the sector has enjoyed a significant rally after bouncing off its uptrend support and now consolidating near several major Simple Moving Averages (SMA).May 10, 2024 | marketbeat.comWill the Biotech Sector Shift From Lagger to Leader? (VRTX)The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs.May 9, 2024 | marketbeat.comBronte Capital Management Pty Ltd. Acquires New Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Bronte Capital Management Pty Ltd. purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 20,760 shares of the pharmace Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election. See who it is HERE. VRTX Media Mentions By Week VRTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTX News Sentiment▼0.800.89▲Average Medical News Sentiment VRTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTX Articles This Week▼3013▲VRTX Articles Average Week Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Regeneron Pharmaceuticals News Sanofi News GSK News Bristol-Myers Squibb News Zoetis News Pfizer News Abbott Laboratories News Takeda Pharmaceutical News Novartis News Royalty Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRTX) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersNext President (Not Trump. Not Biden.)The Freeport SocietyTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
